Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery

Background: It was believed that inflammatory response induced by cardiopulmonary bypass (CPB) was blamed for complications after cardiac surgery. To improve the outcome, many pharmacological interventions have been applied to attenuate inflammatory response during CPB. The objective of this study w...

Full description

Bibliographic Details
Main Authors: Yan Qiu, Jing Lin, Yang Yang, Jing Zhou, Li-Na Gong, Zhen Qin, Lei Du
Format: Article
Language:English
Published: Wolters Kluwer 2015-01-01
Series:Chinese Medical Journal
Subjects:
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=23;spage=3138;epage=3142;aulast=Qiu
id doaj-a544e2ccebd742f6a36aa6b8db509073
record_format Article
spelling doaj-a544e2ccebd742f6a36aa6b8db5090732020-11-25T00:01:31ZengWolters KluwerChinese Medical Journal0366-69992015-01-01128233138314210.4103/0366-6999.170364Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass SurgeryYan QiuJing LinYang YangJing ZhouLi-Na GongZhen QinLei DuBackground: It was believed that inflammatory response induced by cardiopulmonary bypass (CPB) was blamed for complications after cardiac surgery. To improve the outcome, many pharmacological interventions have been applied to attenuate inflammatory response during CPB. The objective of this study was to investigate the effect of ulinastatin (urinary trypsin inhibitor [UTI]) on outcome after CPB surgery. Methods: Totally, 208 patients undergoing elective valves replacement between November 2013 and September 2014 were divided into Group U (n = 70) and Group C (n = 138) based on they received UTI or not. Categorical variables were compared between groups using Fisher's exact test, and continuous variables using unpaired Student's t-test or Mann–Whitney U-test. One-way analysis of variance and Dunnett's or Tukey's tests were used to compare values at different time points within the same group. The risk of outcomes was estimated and adjusted by multivariable logistic regression, propensity scoring, and mixed-effect models for all measured variables. Results: Both the serious complications in total, including death, acute lung injury, acute respiratory distress syndrome and acute kidney injury, and the other complications, including hemodialysis, infection, re-incubation, and tracheotomy were similar between the two groups (P > 0.05). After adjusted by multivariable logistic regression and the propensity score, UTI still cannot be found any benefit to improve any outcomes after cardiac surgery. Also, no statistical differences with regard to duration of postoperative mechanical ventilation, the length of Intensive Care Unit and hospital stays (P > 0.05). Conclusion: UTI did not improve postoperative outcomes in our patients after cardiopulmonary bypass surgery.http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=23;spage=3138;epage=3142;aulast=QiuCardiopulmonary Bypass; Outcomes; Ulinastatin; Valves Replacement
collection DOAJ
language English
format Article
sources DOAJ
author Yan Qiu
Jing Lin
Yang Yang
Jing Zhou
Li-Na Gong
Zhen Qin
Lei Du
spellingShingle Yan Qiu
Jing Lin
Yang Yang
Jing Zhou
Li-Na Gong
Zhen Qin
Lei Du
Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
Chinese Medical Journal
Cardiopulmonary Bypass; Outcomes; Ulinastatin; Valves Replacement
author_facet Yan Qiu
Jing Lin
Yang Yang
Jing Zhou
Li-Na Gong
Zhen Qin
Lei Du
author_sort Yan Qiu
title Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
title_short Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
title_full Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
title_fullStr Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
title_full_unstemmed Lack of Efficacy of Ulinastatin Therapy During Cardiopulmonary Bypass Surgery
title_sort lack of efficacy of ulinastatin therapy during cardiopulmonary bypass surgery
publisher Wolters Kluwer
series Chinese Medical Journal
issn 0366-6999
publishDate 2015-01-01
description Background: It was believed that inflammatory response induced by cardiopulmonary bypass (CPB) was blamed for complications after cardiac surgery. To improve the outcome, many pharmacological interventions have been applied to attenuate inflammatory response during CPB. The objective of this study was to investigate the effect of ulinastatin (urinary trypsin inhibitor [UTI]) on outcome after CPB surgery. Methods: Totally, 208 patients undergoing elective valves replacement between November 2013 and September 2014 were divided into Group U (n = 70) and Group C (n = 138) based on they received UTI or not. Categorical variables were compared between groups using Fisher's exact test, and continuous variables using unpaired Student's t-test or Mann–Whitney U-test. One-way analysis of variance and Dunnett's or Tukey's tests were used to compare values at different time points within the same group. The risk of outcomes was estimated and adjusted by multivariable logistic regression, propensity scoring, and mixed-effect models for all measured variables. Results: Both the serious complications in total, including death, acute lung injury, acute respiratory distress syndrome and acute kidney injury, and the other complications, including hemodialysis, infection, re-incubation, and tracheotomy were similar between the two groups (P > 0.05). After adjusted by multivariable logistic regression and the propensity score, UTI still cannot be found any benefit to improve any outcomes after cardiac surgery. Also, no statistical differences with regard to duration of postoperative mechanical ventilation, the length of Intensive Care Unit and hospital stays (P > 0.05). Conclusion: UTI did not improve postoperative outcomes in our patients after cardiopulmonary bypass surgery.
topic Cardiopulmonary Bypass; Outcomes; Ulinastatin; Valves Replacement
url http://www.cmj.org/article.asp?issn=0366-6999;year=2015;volume=128;issue=23;spage=3138;epage=3142;aulast=Qiu
work_keys_str_mv AT yanqiu lackofefficacyofulinastatintherapyduringcardiopulmonarybypasssurgery
AT jinglin lackofefficacyofulinastatintherapyduringcardiopulmonarybypasssurgery
AT yangyang lackofefficacyofulinastatintherapyduringcardiopulmonarybypasssurgery
AT jingzhou lackofefficacyofulinastatintherapyduringcardiopulmonarybypasssurgery
AT linagong lackofefficacyofulinastatintherapyduringcardiopulmonarybypasssurgery
AT zhenqin lackofefficacyofulinastatintherapyduringcardiopulmonarybypasssurgery
AT leidu lackofefficacyofulinastatintherapyduringcardiopulmonarybypasssurgery
_version_ 1725441676214796288